Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Differential Effects of Meloxicam on Pentylenetetrazole- and Maximal Electroshock-Induced Convulsions in Mice

Hadi Darvishi 1 , Mohsen Rezaei 2 , Mohammad Javad Khodayar 1 , 3 , * , Hamid Reza Zargar 1 , Mohammad Amin Dehghani 1 , 3 , Hossein Rajabi Vardanjani 1 and Sahebeh Ghanbari 1
Authors Information
1 Department of Toxicology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Faculty of Medical Sciences, Department of Toxicology, Tarbiat Modares University, Tehran, Iran
3 Toxicology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: May 2017, 12 (2); e36412
  • Published Online: September 18, 2016
  • Article Type: Research Article
  • Received: January 17, 2016
  • Revised: August 31, 2016
  • Accepted: September 5, 2016
  • DOI: 10.5812/jjnpp.36412

To Cite: Darvishi H, Rezaei M, Khodayar M J, Reza Zargar H, Dehghani M A, et al. Differential Effects of Meloxicam on Pentylenetetrazole- and Maximal Electroshock-Induced Convulsions in Mice, Jundishapur J Nat Pharm Prod. 2017 ; 12(2):e36412. doi: 10.5812/jjnpp.36412.

Abstract
Copyright © 2016, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Dhir A, Naidu PS, Kulkarni SK. Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice. Clin Exp Pharmacol Physiol. 2005; 32(7): 574-84[DOI][PubMed]
  • 2. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia. 2005; 46(11): 1724-43[DOI][PubMed]
  • 3. Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun. 2008; 22(6): 797-803[DOI][PubMed]
  • 4. Vezzani A, Baram TZ. New roles for interleukin-1 Beta in the mechanisms of epilepsy. Epilepsy Curr. 2007; 7(2): 45-50[DOI][PubMed]
  • 5. Choi J, Koh S. Role of brain inflammation in epileptogenesis. Yonsei Med J. 2008; 49(1): 1-18[DOI][PubMed]
  • 6. Takemiya T, Matsumura K, Yamagata K. Roles of prostaglandin synthesis in excitotoxic brain diseases. Neurochem Int. 2007; 51(2-4): 112-20[DOI][PubMed]
  • 7. Rijkers K, Majoie HJ, Hoogland G, Kenis G, De Baets M, Vles JS. The role of interleukin-1 in seizures and epilepsy: a critical review. Exp Neurol. 2009; 216(2): 258-71[DOI][PubMed]
  • 8. Mirhadi K. Anticonvulsant effect of celecoxib in mice induced by PTZ. Middle-East J Sci Res. 2012; 11(3): 272-8
  • 9. Haiju Z, Ruopeng S, Gefei L, Lu Y, Chunxi L. Cyclooxygenase-2 inhibitor inhibits the hippocampal synaptic reorganization by inhibiting MAPK/ERK activity and modulating GABAergic transmission in pilocarpine-induced status epilepticus rats. Med Chem Res. 2008; 18(2): 71-90[DOI]
  • 10. Gates BJ, Nguyen TT, Setter SM, Davies NM. Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety. 2005;
  • 11. Tegeder I, Neupert W, Guhring H, Geisslinger G. Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs. J Pharmacol Exp Ther. 2000; 292(3): 1161-8[PubMed]
  • 12. Engelhardt G, Bögel R, Schnitzler C, Utzmann R. Meloxican: Influence on arachidonic acid metabolism. Biochem Pharmacol. 1996; 51(1): 29-38[DOI]
  • 13. Kalonia H, Kumar A. Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats. Life Sci. 2011; 88(17-18): 784-91[DOI][PubMed]
  • 14. Edfawy M, Hassan MH, Mansour A, Hamed AA, Amin HA. Meloxicam modulates oxidative stress status, inhibits prostaglandin E2, and abrogates apoptosis in carbon tetrachloride-induced rat hepatic injury. Int J Toxicol. 2012; 31(3): 276-86[DOI][PubMed]
  • 15. Gurocak S, Ure I, Cumaoglu A, Gonul I, Sen I, Tan O, et al. Renal tissue damage after experimental pyelonephritis: role of antioxidants and selective cyclooxygenase-2 inhibitors. Urol. 2010; 76(2): 1-5
  • 16. Roughan JV, Wright-Williams SL, Flecknell PA. Automated analysis of postoperative behaviour: assessment of HomeCageScan as a novel method to rapidly identify pain and analgesic effects in mice. Lab Anim. 2009; 43(1): 17-26[DOI][PubMed]
  • 17. Sayyah M, Mandgary A, Kamalinejad M. Evaluation of the anticonvulsant activity of the seed acetone extract of Ferula gummosa Boiss. against seizures induced by pentylenetetrazole and electroconvulsive shock in mice. J Ethnopharmacol. 2002; 82(2-3): 105-9[DOI]
  • 18. Luszczki JJ, Glowniak K, Czuczwar SJ. Time-course and dose-response relationships of imperatorin in the mouse maximal electroshock seizure threshold model. Neurosci Res. 2007; 59(1): 18-22[DOI][PubMed]
  • 19. Peterson SL. Glycine potentiation of anticonvulsant drugs in pentylenetetrazol seizures in rats. Brain Res Bull. 1991; 26(1): 43-7[PubMed]
  • 20. Loscher W, Honack D, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res. 1991; 8(3): 171-89[PubMed]
  • 21. Namvaran A, Tavakkoli G. The effect of Salvia officinalis hydroalcoholic extract on PTZ-induced seizure threshold in Vincristine injected mice. 2012;
  • 22. Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carney JM, Floyd RA. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci U S A. 1990; 87(13): 5144-7[PubMed]
  • 23. Abbasnejad M, Keramat B, Mahani E, Rezaeezade-Roukerd M. Effect of hydro-methanolic extract of sour orange flowers, Citrus aurantium, on pentylentetrazole induced seizure in male rats. J Babol Univ Med S. 2012; 14(5): 20-8
  • 24. Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, et al. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Neuroscience. 2006; 141(3): 1149-62[DOI][PubMed]
  • 25. Cernak I, O'Connor C, Vink R. Activation of cyclo-oxygenase-2 contributes to motor and cognitive dysfunction following diffuse traumatic brain injury in rats. Clin Exp Pharmacol Physiol. 2001; 28(11): 922-5[PubMed]
  • 26. Nakayama M, Uchimura K, Zhu RL, Nagayama T, Rose ME, Stetler RA, et al. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci U S A. 1998; 95(18): 10954-9[PubMed]
  • 27. Katyal J, Kumar H, Gupta YK. Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment. Epilepsy Behav. 2015; 44: 98-103[DOI][PubMed]
  • 28. Takemiya T, Suzuki K, Sugiura H, Yasuda S, Yamagata K, Kawakami Y, et al. Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Other Lipid Mediat. 2003; 71(3-4): 205-16[PubMed]
  • 29. Dhir A, Kulkarni SK. Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice. Inflammopharmacology. 2006; 14(5-6): 222-5[DOI][PubMed]
  • 30. Wallenstein MC, Mauss EA. Effect of prostaglandin synthetase inhibitors on experimentally induced convulsions in rats. Pharmacology. 1984; 29(2): 85-93[PubMed]
  • 31. Hakan T, Toklu HZ, Biber N, Ozevren H, Solakoglu S, Demirturk P, et al. Effect of COX-2 inhibitor meloxicam against traumatic brain injury-induced biochemical, histopathological changes and blood-brain barrier permeability. Neurol Res. 2010; 32(6): 629-35[DOI][PubMed]
  • 32. Kim HJ, Chung JI, Lee SH, Jung YS, Moon CH, Baik EJ. Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors. Brain Res. 2008; 1193: 153-61[DOI][PubMed]
  • 33. Dhir A, Naidu PS, Kulkarni SK. Effect of cyclooxygenase-2 (COX-2) inhibitors in various animal models (bicuculline, picrotoxin, maximal electroshock-induced convulsions) of epilepsy with possible mechanism of action. Indian J Exp Biol. 2006; 44(4): 286-91[PubMed]
  • 34. Dhir A, Naidu PS, Kulkarni SK. Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice. Seizure. 2007; 16(8): 691-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments